Keywords: Muscle, CEST / APT / NOE, CMT, fat accumulation
Motivation: There remains an unmet need for sensitive biomarkers for CMT disease progression.
Goal(s): To explore the feasibility of evaluating CMT1A progression based on saturation transfer imaging of phosphocreatine, creatine, and glycogen at 5T.
Approach: Phosphocreatine and total creatine were detected via CEST effects at +2.6 ppm and +2.0 ppm of Z-spectrum, respectively, and glycogen was measured by relayed nuclear Overhauser effects at -1.0 ppm.
Results: Preliminary results showed an apparent decrease of PCrCEST and glycoNOE signals in the calf muscles of CMT1A patients, with the extent of signal reduction correlating with CMT1A severity.
Impact: Simultaneous monitoring of Cr, PCr and glycogen in muscle holds potential for tracking CMT progression and may offer a promising non-invasive approach for monitoring muscular disorders in humans.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords